1,3-dihydroxyisopropyl methacrylate | 69068-66-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油脂
• 英文名称: 1,3-dihydroxyisopropyl methacrylate
• 英文别名: 2-hydroxy-1-(hydroxymethyl)ethyl methacrylate；2-glycerol monomethacrylate；DHIPMA；glycerol monomethacrylate；glycerin monomethacrylate；glycerine methacrylate；glycerol methacrylate；2-Propenoic acid, 2-methyl-, 2-hydroxy-1-(hydroxymethyl)ethyl ester；1,3-dihydroxypropan-2-yl 2-methylprop-2-enoate
• CAS: 69068-66-2
• 化学式: C₇H₁₂O₄
• 分子量: 160.17
• InChiKey: WMWOVDPNCMAJPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  甲基丙烯酸缩水甘油酯 在 水 作用下， 反应 5.0h， 生成 2-甲基-2-丙烯酸-2,3-二羟基丙酯 、 1,3-dihydroxyisopropyl methacrylate
  参考文献：
  名称：

  Inverse high internal phase emulsion polymerization (i-HIPE) of GMMA, HEMA and GDMA for the preparation of superporous hydrogels as a tissue engineering scaffold

  摘要：

  通过反转高内相乳液（i-HIPE）聚合制备超多孔水凝胶作为组织工程支架。

  DOI：

  10.1039/c5tb01873k

文献信息

• METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS
  申请人：Driver Michael

  公开号：US20130059926A1

  公开（公告）日：2013-03-07

  A method for producing polymerisable solution which comprises dissolving an ethylenically unsaturated zwitterionic monomer in a co-monomer system comprising a functionalised ethylenically unsaturated monomer in which the zwitterionic monomer is soluble, a siloxane group-containing monomer or macromer, and a crosslinking agent is disclosed. The polymerisable solution is biocompatible and can be used to produce polymers and articles such as contact lenses.

  一种生产可聚合溶液的方法，该方法包括将一种乙烯基不饱和的两性离子单体溶解在共单体系统中，该共单体系统包括一种功能性乙烯基不饱和单体，在该单体中两性离子单体是可溶的，一种含有硅氧烷基团的单体或大单体，以及一种交联剂。所述的可聚合溶液具有生物相容性，可用于生产聚合物和制品，如隐形眼镜。
• [EN] PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME<br/>[FR] PHOTOAMORCEUR ET COMPOSITION PHOTOSENSIBLE LE CONTENANT
  申请人：TAKOMA TECHNOLOGY CO LTD

  公开号：WO2015080503A1

  公开（公告）日：2015-06-04

  Provided is a photoinitiator represented by Formula 1: The photoinitiator is suitable for photocrosslinking. Further provided is a photosensitive resin composition including the photoinitiator. The photoinitiator and the photosensitive resin composition have improved solubility and high sensitivity. The photosensitive resin composition is suitable for use in the production of black resists, color resists, overcoats, column spacers, and organic insulating films for LCDs.

  提供的是由化学式1表示的光引发剂：该光引发剂适用于光交联。进一步提供了包括该光引发剂的光敏树脂组合物。该光引发剂和光敏树脂组合物具有改善的溶解性和高灵敏度。该光敏树脂组合物适用于用于生产黑色光阻剂、彩色光阻剂、覆盖层、柱间隔以及液晶显示器的有机绝缘膜。
• PRODUCTION OF OPHTHALMIC DEVICES BASED ON PHOTO-INDUCED STEP GROWTH POLYMERIZATION
  申请人：Medina Arturo Norberto

  公开号：US20110269869A1

  公开（公告）日：2011-11-03

  The invention provide a new lens curing method for making hydrogel contact lenses. The new lens curing method is based on actinically-induced step-growth polymerization. The invention also provides hydrogel contact lenses prepared from the method of the invention and fluid compositions for making hydrogel contact lenses based on the new lens curing method. In addition, the invention provide prepolymers capable of undergoing actinically-induced step-growth polymerization to form hydrogel contact lenses.

  这项发明提供了一种新的透镜固化方法，用于制造水凝胶隐形眼镜。这种新的透镜固化方法基于光引发的步聚合反应。该发明还提供了通过该发明方法制备的水凝胶隐形眼镜，以及基于新的透镜固化方法制造水凝胶隐形眼镜的液体组合物。此外，该发明提供了能够经历光引发的步聚合反应形成水凝胶隐形眼镜的预聚合物。
• [EN] POLYMER-CYCLODEXTRIN-LIPID CONJUGATES<br/>[FR] CONJUGUÉS POLYMÈRE-CYCLODEXTRINE-LIPIDE
  申请人：WU NIAN

  公开号：WO2016209732A1

  公开（公告）日：2016-12-29

  The invention comprises compounds, methods of making, and methods of using. A group of polymer-cyclodextrin-lipid conjugates having a center backbone and three or four appended functional groups are disclosed, wherein one of the hydrophilic components is cyclodextrin. The compounds may have a backbone with three or four appended functional groups: one or two lipophilic compounds including sterols or "fat soluble" vitamins or fatty acids, one or two hydrophilic polymer and one cyclodextrin. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. Typical coupling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the center backbone and functional groups may also be selected to modify the carriers or center backbones for the coupling reactions and optimize performance of the conjugates.

  该发明涵盖了化合物、制备方法和使用方法。公开了一组具有中心骨架和三个或四个附加功能基团的聚合物-环糊精-脂质共轭物，其中一个亲水成分是环糊精。这些化合物可能具有一个带有三个或四个附加功能基团的骨架：一个或两个疏水化合物，包括甾醇或“脂溶性”维生素或脂肪酸，一个或两个亲水性聚合物和一个环糊精。特定的功能基团可以针对制备药物、化妆品、营养保健品等特定应用进行选择。共轭物的典型偶联反应可能涉及一种或多种或组合或串联的烷基化，包括N-烷基化或O-烷基化，醚化，酯化和酰胺化化学过程。还可以选择各种连接剂连接中心骨架和功能基团，以修改载体或中心骨架用于偶联反应并优化共轭物的性能。
• [EN] FLUOROSILOXANE MATRIX CONTROLLED DIFFUSION DRUG DELIVERY SYSTEM<br/>[FR] SYSTEME D'APPORT DE MEDICAMENT A DIFFUSION REGULEE A MATRICE DE FLUOROSILOXANE
  申请人：BAUSCH & LOMB

  公开号：WO2004000288A1

  公开（公告）日：2003-12-31

  Fluorinated side-chain siloxane copolymeric matrix controlled diffusion drug delivery systems are provided that allow controlled release of sustained concentrations of therapeutic agents within a treated area for a prolonged period of time. The favorable solubility characteristics of the fluorinated sidechains of the siloxane copolymeric matrix controlled diffusion drug delivery systems allow for manipulation of drug release rates depending on the particular therapeutic use and the particular needs of the patient.

  提供了氟化侧链硅氧烷共聚基质控制扩散药物输送系统，允许在治疗区域内控制释放持续浓度的治疗剂，以延长时间。氟化侧链硅氧烷共聚基质控制扩散药物输送系统的有利溶解特性允许根据特定治疗用途和患者特定需求来操纵药物释放速率。